Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.35 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18178197 | 0.93 | CD274 (0.37) | PTGER1CD274MRGPRX4MAPK14PDCD1 | |
| SCHEMBL18178187 | 0.92 | PTGER1 (0.35) | PTGER1CD274MRGPRX4MAPK14PDCD1 | |
| SCHEMBL18182365 | 0.91 | ABCG2 (0.35) | PTGER1MAPK14KDM4EALDH1A1TDP1 | |
| SCHEMBL18178372 | 0.91 | CD274 (0.38) | CD274PDCD1KDM4EALDH1A1TDP1 | |
| SCHEMBL18178572 | 0.90 | MRGPRX4 (0.36) | PTGER1CD274MRGPRX4MAPK14PDCD1 | |
| SCHEMBL18178128 | 0.90 | MRGPRX4 (0.40) | PTGER1CD274MRGPRX4KDM4EALDH1A1 | |
| SCHEMBL18178178 | 0.90 | MRGPRX4 (0.42) | PTGER1MRGPRX4KDM4EALDH1A1HPGD | |
| SCHEMBL18178150 | 0.90 | PTGER1 (0.40) | PTGER1MRGPRX4MAPK14KDM4EHPGD | |
| SCHEMBL18178151 | 0.90 | MRGPRX4 (0.37) | PTGER1CD274MRGPRX4MAPK14KDM4E | |
| SCHEMBL18178153 | 0.90 | SLC22A12 (0.39) | PTGER1CD274MRGPRX4MAPK14KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573904-B2 | Aromatic compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | ZCCHC8, CBR3, CBX8 | PTGER1 4234/4885CD274 3579/4885MRGPRX4 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.